Does BLEOMYCIN Cause Malignant neoplasm progression? 137 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Malignant neoplasm progression have been filed in association with BLEOMYCIN (Bleomycin). This represents 2.0% of all adverse event reports for BLEOMYCIN.
137
Reports of Malignant neoplasm progression with BLEOMYCIN
2.0%
of all BLEOMYCIN reports
59
Deaths
35
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BLEOMYCIN?
Of the 137 reports, 59 (43.1%) resulted in death, 35 (25.5%) required hospitalization, and 10 (7.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLEOMYCIN. However, 137 reports have been filed with the FAERS database.
What Other Side Effects Does BLEOMYCIN Cause?
Off label use (656)
Febrile neutropenia (632)
Neutropenia (433)
Drug ineffective (395)
Pyrexia (291)
Product use in unapproved indication (280)
Pulmonary toxicity (263)
Thrombocytopenia (260)
Nausea (255)
Anaemia (252)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BLEOMYCIN Alternatives Have Lower Malignant neoplasm progression Risk?
BLEOMYCIN vs BLINATUMOMAB
BLEOMYCIN vs BLONANSERIN
BLEOMYCIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLEOMYCIN vs BOCEPREVIR
BLEOMYCIN vs BOCOCIZUMAB